Ftse Mib
33.940,62
0,93%
DAX
18.157,63
0,91%
S&P 500
5.156,14
0,55%
NASDAQ
16.246,19
0,56%
Bitcoin
63.184,93
-1,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pliant Therapeutics Inc (PLRX) Pliant Therapeutics Inc (PLRX) Notizie

Pliant Therapeutics Inc

PLRX
13,875
-0,105 (-0,75%)
Ultimo aggiornamento: 17:06:29
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02/4/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27/3/202415:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12/3/202412:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
27/2/202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:06EDGAR2Form 8-K - Current report
27/2/202422:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26/2/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
15/2/202402:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
05/2/202413:31EDGAR2Form 8-K - Current report
04/2/202421:29GLOBEPliant Therapeutics Announces Positive Safety and..
24/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202414:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
13/11/202322:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
09/11/202322:11EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
08/11/202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
06/11/202314:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
31/10/202321:03GLOBEPliant Therapeutics Announces Three Presentations at the..
19/10/202314:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
16/10/202322:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
03/10/202322:53EDGAR2Form 8-K - Current report
26/9/202313:34EDGAR2Form 8-K - Current report
26/9/202313:30GLOBEPliant Therapeutics Announces Positive Safety and..
25/9/202322:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
15/9/202314:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
11/9/202314:00GLOBEPliant Therapeutics Announces Presentations at the European..
30/8/202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
28/8/202322:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
09/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:05EDGAR2Form 8-K - Current report
09/8/202322:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
09/8/202314:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
25/7/202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
21/7/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:06EDGAR2Form 144 - Report of proposed sale of securities
20/7/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202302:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 14,09 Min: 13,7856 Max: 14,33
Chiusura: 13,98

La tua Cronologia

NASDAQ
PLRX
Pliant Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network